We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Preventing Rheumatoid Arthritis Requires a Mixed Population of Regulatory T-cells

By LabMedica International staff writers
Posted on 23 May 2012
A recent article discussed the latest thinking regarding the molecular aspects of how the immune system guards itself from the development of autoimmune disorders such as rheumatoid arthritis and why this system sometimes fails.

A white blood cell cocktail containing CD4+CD25+Foxp3+ regulatory T-cells (Tregs) is required to restrain the immune system from mounting an autoaggressive systemic inflammatory response. More...
Rheumatoid arthritis is an autoimmune disorder that occurs when this protection fails and the immune system attacks the synovium, the membrane that lines all the joints of the body. It is a common disorder that causes pain, redness, and swelling around the joints. It has been estimated that approximately one percent of the adult population, worldwide, suffers from rheumatoid arthritis.

Investigators at The Wistar Institute (Philadelphia, PA; USA) used a mouse model of spontaneous autoimmune arthritis. These animals had been genetically engineered to express a “self” molecule - a clonotypic T-cell receptor (TCR) - that induced arthritis by an IL-17–dependent mechanism. The investigators then determined how TCR specificity contributed to Treg activity.

Results published in the May 1, 2012, issue of the Journal of Immunology revealed that administration of polyclonal Tregs suppressed Th17 cell formation and prevented arthritis development. Treatment with Tregs that expressed only the clonotypic TCR did not prevent development of arthritis.

“Our results show, surprisingly, that suppressing the immune response against a single target will not shut down the inflammatory response that causes rheumatoid arthritis,” said senior author Dr. Andrew J. Caton, professor in The Wistar Institute’s tumor microenvironment and metastasis program. “Instead, an array of inflammation-stimulating antigens may be involved in causing the disease, since our study shows that an array of regulatory T-cells is required to temper the immune system’s attack on joints.”

“The big unanswered question of rheumatoid arthritis is ‘why are joints targeted’?” said Dr. Caton. “Of all the tissues in the body, of all the places our immune system could attack, this question remains. One idea is that the immune system is not deliberately attacking joints in patients with rheumatoid arthritis, but the joint inflammation is a side effect of the natural tendency of these cells to accumulate in these areas of the body.”

Related Links:

The Wistar Institute



Gold Member
Neonatal Heel Incision Device
Tenderfoot
Online QC Software
Acusera 24•7
Immunofluorescence Analyzer
IFA System
Urine Analyzer
respons® UDS100
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Characterization of EV separated by distinct methods (Photo courtesy of Yuanyuan Liu, Yanbin Guo et al. Engineering, doi.org/10.1016/j.eng.2025.12.009)

Liquid Biopsy Biomarkers May Improve Childhood Epilepsy Diagnosis

Childhood epilepsy remains a major neurological disorder with unmet needs for accurate, non-invasive biomarkers, as conventional tests such as electroencephalography and neuroimaging can have limited sensitivity... Read more

Molecular Diagnostics

view channel
Image: Associate Professor Arutha Kulasinghe and non-small cell lung cancer cell (Photo courtesy of The University of Queensland)

Blood-Based Proteomic Test May Predict Treatment Response in Non-Small Cell Lung Cancer

Lung cancer remains the leading cause of cancer death, with non-small cell lung cancer (NSCLC) accounting for most cases. Treatment decisions are often made without a clear indication of how a patient... Read more

Pathology

view channel
Image: Immune-related signals in routine bone marrow biopsy slides could help predict multiple myeloma outcomes and support more personalized treatment strategies (image credit: Shutterstock)

AI Tool Extracts Immune Signals from Biopsy to Inform Myeloma Therapy

Multiple myeloma is a bone marrow malignancy in which patients can respond very differently to the same treatments, making initial therapy decisions difficult. Clinicians must choose among options such... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.